FDA Inspection 1117366 — Allergan Pharmaceuticals Ireland
The FDA completed an inspection of Allergan Pharmaceuticals Ireland on May 4, 2018 in Westport. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 4, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Westport (Ireland)
Additional Details
Mutual Recognition Agreement (MRA)